Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Delta-9-tetrahydrocannabinol measurement |
Has measured component |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Delta-9-tetrahydrocannabinol measurement |
Component |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Delta-9-tetrahydrocannabinol 27mg/mL/cannabinol 25mg/mL buccal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cannabinol and delta-9-tetrahydrocannabinol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dronabinol (substance) |
Is a |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only cannabinol and delta-9-tetrahydrocannabinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
Has precise active ingredient |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing cannabidiol and delta-9-tetrahydrocannabinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cannabidiol and delta-9-tetrahydrocannabinol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cannabidiol- and delta-9-tetrahydrocannabinol-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cannabidiol and delta-9-tetrahydrocannabinol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |